AstraZeneca leads big pharma’s AI clinical trials revolution with real-world patient impact
Big Pharma’s AI race extends across drug discovery, development, and clinical trials—but AstraZeneca has distinguished itself by deploying AI clinical trials technology at an unprecedented public health scale. While competitors optimise internal R&D pipelines, AstraZeneca’s AI is already embedded in national healthcare systems, screening hundreds of thousands of patients and demonstrating what happens when AI […]
The post AstraZeneca leads big pharma’s AI clinical trials revolution with real-world patient impact appeared first on AI News.
JPMorgan Chase AI strategy: US$18B bet paying off
JPMorgan Chase’s AI strategy is delivering measurable returns – but at a human cost. The bank isn’t hiding the fact. With 200,000 employees now using its proprietary LLM Suite platform daily and AI benefits growing 30-40% annually, America’s largest bank is executing what Chief Analytics Officer Derek Waldron calls a plan to create the world’s […]
The post JPMorgan Chase AI strategy: US$18B bet paying off appeared first on AI News.